Open AccessRemdesivir Approved to Treat COVID-19 Amid Controversy
Author(s) -
Diane S. Aschenbrenner
Publication year - 2021
Publication title -
the american journal of nursing/american journal of nursing
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.23
H-Index - 57
eISSN - 1538-7488
pISSN - 0002-936X
DOI - 10.1097/01.naj.0000731640.35662.2c
Subject(s) - covid-19 , betacoronavirus , medicine , coronavirus infections , pandemic , virology , medline , intensive care medicine , political science , law , outbreak , infectious disease (medical specialty) , disease
Remdesivir (Veklury) is the first antiviral drug approved to treat patients ages 12 and older who are hospitalized with COVID-19.The drug is administered via slow IV infusion.Elevated liver enzymes are common with treatment. Hypersensitivity reactions, including anaphylaxis, are possible.